Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development
This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification.
This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.
Table of Contents
Ecosystem
Scope of Analysis
Segmentation
Growth Environment: Transformation in Clinical Next-generation Sequencing
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Clinical Next-generation Sequencing Industry
Ecosystem in Clinical Next-generation Sequencing
Competitive Environment
Key Competitors
Growth Generator in Clinical Next-generation Sequencing
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Considerations
Revenue Forecast
Revenue Forecast by Product
Revenue Forecast by Workflow
Revenue Forecast by Application
Revenue Forecast by Region
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Revenue Share
Revenue Share Analysis
Competitive Players
Company Informatics Solutions for Applications
Growth GeneratorInstruments
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth GeneratorWorkflow Solutions
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth GeneratorServices
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth GeneratorInformatics
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity Universe Analysis of the Clinical Next-generation Sequencing Sector
Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine
Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer
Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research
Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA